Casdin Capital’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,000	Closed	-$1.33M	–	52
2020 Q4	$1.33M	Buy	+40,000	New	+$1.33M	0.04%	50